Menu
  • Join
  • Login
  • Contact
 

Search abstracts


The Efficacy Comparison Between Mirabegron and Antimuscarinics in Treating Overactive Bladder: a Systematic Review and Meta-Analysis

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: CHEN, Hsiao Ling (Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung,Taiwan, Pharmacy, Kaohsiung City, China Taiwan)
  • Co-author(s): Hsiao Ling Chen: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Tun-Cheh Chen: Division of Infectious Diseases, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Hsiang Ying Lee: Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Wei-Hsuan Huang: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Hung-Fang Pan: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Chiou-Mei Wu: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Ya-Ling Wang: Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan, Province of China
    Hsiu-Mei Chang: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
    Yong-Chieh Chang: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
  • Abstract:

    Backgrounds

    Antimuscarinic drugs have been the first line choice of overactive bladder (OAB) treatment; however, side effects were clearly a major reason for noncompliance. Mirabegron, a β3-adrenoceptor agonist, was investigated to be effective and safe for OAB.

    Aims

    To perform a meta-analysis on the efficacy comparison between antimuscarinics and

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses